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Hypoxic pulmonary vasoconstriction is correlated with pulmonary
vascular remodeling. The hypoxia-inducible transcription factors (HIFs)
HIF-1α and HIF-2α are known to contribute to the process of hypoxic
pulmonary vascular remodeling; however, the specific role of pulmo-
nary endothelial HIF expression in this process, and in the physiological
process of vasoconstriction in response to hypoxia, remains unclear.
Here we show that pulmonary endothelial HIF-2α is a critical regulator
of hypoxia-induced pulmonary arterial hypertension. The rise in right
ventricular systolic pressure (RVSP) normally observed following
chronic hypoxic exposure was absent in mice with pulmonary endo-
thelial HIF-2α deletion. The RVSP of mice lacking HIF-2α in pulmonary
endothelium after exposure to hypoxia was not significantly different
from normoxic WT mice and much lower than the RVSP values seen in
WT littermate controls and mice with pulmonary endothelial deletion
of HIF-1α exposed to hypoxia. Endothelial HIF-2α deletion also pro-
tected mice from hypoxia remodeling. Pulmonary endothelial deletion
of arginase-1, a downstream target of HIF-2α, likewise attenuated
many of the pathophysiological symptoms associated with hypoxic
pulmonary hypertension. We propose a mechanism whereby chronic
hypoxia enhances HIF-2α stability, which causes increased arginase
expression and dysregulates normal vascular NO homeostasis. These
data offer new insight into the role of pulmonary endothelial HIF-2α in
regulating the pulmonary vascular response to hypoxia.
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Alveolar hypoxia affects vascular flow in the pulmonary vascularbed via an immediate vasoconstrictor response (hypoxic pul-
monary vasoconstriction, or HPV) (1). This reduces perfusion of
regions of the lung with lowered levels of airflow (2). In conditions
including chronic obstructive pulmonary disease (3), idiopathic
pulmonary fibrosis (4), and at high altitude (5), HPV probably
contributes to persistent increases in pulmonary arterial pressures.
This in turn is correlated with reduced plasticity of the vascular bed,
sustained pulmonary vascular remodeling, and, ultimately, debili-
tating right ventricular hypertrophy (RVH) and failure (2).
The hypoxia-inducible factors (HIFs) are transcription fac-
tors and key regulators of the molecular response to hypoxia.
The targets of HIFs include genes controlling vascularization,
cellular proliferation, migration, and metabolism (6–11). A well-
characterized animal model of hypoxia-induced pulmonary hyper-
tension involves exposure to chronic hypoxia (CH), typically 10–12%
inspired oxygen. This results in extensive vascular remodeling,
marked pulmonary hypertension and RVH over a period of a few
weeks. Exposure to CH in rodents results in vasoconstriction and a
pattern of vascular remodeling that is reminiscent of humans with
hypoxia-associated pulmonary hypertension (12, 13).
Mice that are hemizygous for either of the HIF isoforms,
HIF-1α (14) or HIF-2α (15), have been shown to have attenuated
pulmonary vascular remodeling following experimental CH.
Conditional deletion of HIF-1α in smooth muscle also ameliorates
the degree of remodeling in CH (16). The mechanisms by which
HIF acts in pulmonary vascular remodeling are not fully defined;
in particular, the role played by the endothelium in this process is
not well understood. Here, we delete the HIF isoforms and one of
their targets, the Arginase-1 (Arg1) gene, specifically in the pulmonary
endothelium (17), and show that expression of the HIFα transcription
factors in pulmonary endothelial cells is an essential aspect of the
hypoxic response of the lung.
Results
Deletion of HIFα Isoforms in Pulmonary Endothelium. Genetically
manipulated mouse strains with conditional alleles of either the
HIF-1α or -2α isoforms (18, 19) were crossed to mouse strains
expressing the cre recombinase enzyme under the control of the
pulmonary endothelium-specific Alk1- or L1 promoter (L1cre)
(17). To determine tissue specificity of this transgene, we an-
alyzed the cre activity of adult L1cre mice by crossing with a
ROSA26Sortm9(CAG-tdTomato) reporter strain. As shown, lung vas-
culature was easily identifiable. Minimal expression of tdTomato
was detectable in the endothelium of other tissues (Fig. S1A).
Deletion efficiency was assessed and deletion was greater than 80%
(Fig. S1B), with little or no detectable deletion in other tissues.
HIF-2α Deletion in the Pulmonary Endothelium Prevents Hypoxia-
Induced Pulmonary Hypertension. WT and pulmonary endothelial
HIF-α deleted mice were exposed to normoxic or hypoxic (10%
O2) normobaric atmospheres for 21 d. Pulmonary hypertension
was assessed through measurement of right ventricular systolic
pressures (RVSPs) (Fig. 1A). RVSPs in L1cre-HIF-2αmice (18.9 ±
1.0 mmHg, n = 11) under normoxic conditions were significantly
lower than in littermate controls (22.4 ± 1.1 mmHg, n = 9, P =
0.03) mice. However, RVSPs from normoxic L1cre-HIF-1α mice
(24.7 ± 1.7 mmHg, n = 6) did not differ from those of WT controls
(Fig. 1A).
Significance
The expression of hypoxia-inducible factor (HIF)-2α in pulmonary
endothelium ofmice influences pulmonary vascular resistance and
development of hypoxic pulmonary hypertension (PH) via an
arginase-1–dependent mechanism. The HIF-2α:arginase-1 axis in-
fluences the homeostatic regulation of nitric oxide synthesis in the
lung. Impaired generation of this vasoactive agent contributes to
the initial development and vascular remodeling process of PH.
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The RVSPs of L1cre-HIF-2α mice following hypoxic exposure
(26.1 ± 1.6 mmHg, n = 7) were not significantly different from
those of untreated WT mice (22.48 ± 1.19, n = 9) and were much
lower than the elevated values seen in WT littermate controls
(41.9 ± 1.8 mmHg, n = 12, P < 0.0001) and L1cre-HIF-1α mice
(36.25 ± 2.37 mmHg, n = 7, P < 0.005) (Fig. 1A).
The ratio of right ventricular weights to those of the left ven-
tricle plus septum (RV/LS+S), an indicator of RVH, was likewise
significantly higher in WT (0.316 ± 0.01, n = 8, P < 0.0001) and
L1cre-HIF-1α (0.323 ± 0.02, n = 8, P < 0.001) mice exposed to
hypoxia compared with the ratios found in L1cre-HIF-2α (0.209 ±
0.008, n = 8) mice (Fig. 1B). WT and mutant mice reacted to
hypoxia normally in other respects (Fig. S2 A–C).
Pulmonary Endothelial HIF-2α Is Essential for Vascular Remodeling.
Medial thickening of pulmonary vessels was calculated. Both WT
littermates and L1cre-HIF-1α mice showed significantly increased
medial thickness following hypoxic conditioning (Fig. 1C). In
comparison, hypoxic L1cre-HIF-2α mice showed a large relative
reduction in medial thickness relative to WT animals. Normoxic
animals showed no changes in vessel structure (Fig. S3).
Serial lung sections were immunostained to mark endothelial
cells. Lungs from WT and L1cre-HIF-1α mice had typical tissue
remodeling following CH (Fig. 1D), with an increase in α-smooth
muscle actin (α-SMA) associated with pulmonary arteries (Fig.
1E). However, little to no remodeling was observed in lung
sections from L1cre-HIF-2α mice (Fig. 1F). Lung sections showed
increases in elastin in both WT controls and L1cre-HIF-1α mice,
but only minimal staining in the L1cre-HIF-2α mice (Fig. 1D)
(20). Collagen was also significantly higher in hypoxia-conditioned
WT and L1cre-HIF-1α mice relative to L1cre-HIF-2α mice (Fig.
S4A). Pulmonary endothelial deletion of HIF-2α reduced smooth
muscle cell coverage after hypoxic exposure (Fig. 1F). In com-
parison, both WT littermate control and L1cre-HIF-1α mice de-
veloped full and partial rings of α-SMA–positive cells around
vessels in hypoxia-conditioned animals (Fig. 1F).
Reduced Arginase Expression in HIF2α Mutant Mice. Previous work
from our laboratory and others has demonstrated that the two
HIFα isoforms act to control NO homeostasis during hypoxia.
This occurs through HIF1α regulation of the NOS2/iNOS gene,
and HIF-2α regulation of the Arg-1 and Arg-2 genes (21–25).
The enzyme Arg-2 in particular has been implicated in reducing
airway NO and promoting remodeling and collagen deposition in
pulmonary arterial hypertension (PAH) patients (26, 27). We
found that hypoxic up-regulation of arg-1 and -2 was reduced in
hypoxia-conditioned isolated murine primary pulmonary endo-
thelial cells (Fig. S5A) and whole lung samples from L1cre-HIF-2α
mice, relative to WT littermate controls following hypoxic con-
ditioning (Fig. 2A).
Consistent with these data, we found that plasma NO(X) con-
centrations were significantly reduced in HIF-1α mice and ele-
vated in HIF-2α mutant mice compared with WT control mice
(Fig. 2B); this was mirrored in an increase in NO metabolites
detected in whole lung extracts of hypoxically treated animals (Fig.
2C). There was also an increase in exhaled NO detected in HIF-2α
mutant mice (Fig. 2D). Although several recent studies have
highlighted the role of endothelin-1 (ET-1) in pulmonary hyper-
tension and indicated its regulation by the HIF pathway, purified
lung endothelial cells showed little change in ET-1 expression in
this model (Fig. S5 B–D). There was a significant increase in
PDGF-β expression in WT mice during the acute hypoxic phase
(days1–3) before levels returned to near baseline at the chronic
phase (day 21). However, there seems to be little separation be-
tween WT and L1cre-HIF2α mice (Fig. S6 A–D). We further
analyzed a number of stem cell markers known to be up-regulated
in PAH (28). We found enhanced whole lung gene expression of
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Fig. 1. Pulmonary endothelial HIF-2α contributes to chronic hypoxic pul-
monary hypertension. (A) Scatter plot (mean ± SEM) of RVSP. WT and L1cre-
HIFα mice were housed in normoxia (N) or CH (H) [WT (N) n = 9, (H) n = 12;
L1cre-HIF-1α (N) n = 6, (H) n = 7; L1cre-HIF-2α (N) n = 11, (H) n = 7]. (B) RVH.
Scatter plot (mean ± SEM) shows RV/LV+S weight ratio in mice exposed to
normoxia (N) or CH (H) [WT (N) n = 9, (H) n = 12; L1cre-HIF-1α (N) n = 6, (H)
n = 7; L1cre-HIF-2α (N) n = 11, (H) n = 7]. (C and D) Airway remodeling in WT
(n = 15), L1cre-HIF-1α (n = 7), and L1cre-HIF-2α (n = 7) postchronic hypoxic
challenge. (C) Scatter plot (mean ± SEM) of pulmonary vessel medial thick-
ness. Quantification of the intimal medial thickness achieved by staining
lung sections with elastic van Gieson (EVG). (D) Histological sections immu-
nostained with α-SMA, von Willebrand factor (vWF), and EVG. Representa-
tive photomicrographs demonstrate lack of remodeling in L1cre-HIF-2α
pulmonary arteries associated with terminal bronchi. Loss of HIF-2α in
pulmonary endothelial cells reduces the degree of muscularization of
peripheral arteries. (Scale bars, 200 μM.) (E ) Stacked bar chart showing
muscularization of peripheral pulmonary arteries in lung sections (blue
bar, full muscle ring; green bar, partial muscle ring; and yellow bar, no
muscle ring) from WT (n = 15), L1cre-HIF-1α (n = 9), and L1cre-HIF-2α (n = 7)
mice. (F) Representative photomicrographs immunostained for α-smooth
muscle (arrows point to distal vessels). (Scale bars, 100 μM.) *P < 0.05,
**P < 0.001, ***P < 0.0001.
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both Oct3-4 and nanog in WT compared with L1cre-HIF2α mice
(Fig. S6 E–H).
Pulmonary Endothelial Arginase-1 Deletion Attenuates PAH.We next
sought to determine how the specific deletion of arginase-1 in the
pulmonary endothelium influenced the development of PAH. The
increase in RVSP normally observed following chronic hypoxic
challenge (for WTmice, 41.7 ± 0.8 mm/Hg, n = 7, P < 0.0001) was
significantly attenuated in mice with pulmonary endothelial argi-
nase-1 deletion (31.2 ± 1.0 mmHg, n = 7) (Fig. 2E). Basal RVSPs
in L1cre-arg1 mice under normoxia (23.0 ± 0.7 mmHg, n = 6)
were similar to those seen in littermate WT control mice (24.3 ±
0.3 mmHg, n = 5). The RV/LS+S was significantly higher in WT
(0.39 ± 0.01, n = 6, P < 0.001) compared with L1cre-arg1 (0.33 ±
0.01, n = 9) mice, following chronic hypoxic exposure (Fig. 2F);
the animals otherwise responded normally to hypoxia (Fig. S7A).
WT littermates showed significantly greater medial thickening
(18.57%, n = 15) compared with L1cre-arg1 mice (14.35%, n = 9)
after exposure to CH (Fig. 2G). Collagen deposition around the
bronchial-associated vasculature was significantly higher in hypoxically
conditioned WT control mice relative to L1cre-arg1 mice (Fig. S4B).
L1cre-arg1 mice showed substantially less α-SMA associated
with pulmonary arteries in close proximity to terminal bronchioles
compared with WT controls (Fig. S7B). Staining for α-SMA was
also substantially reduced in the peripheral pulmonary vasculature
of these mutants (Fig. 2 H and I). Deletion of pulmonary endo-
thelial arg-1 significantly elevated plasma NO(x) relative to the
levels seen in plasma from WT control mice (Fig. 2J).
Changes in Acute Response to Hypoxia Caused by Loss of Endothelial
HIF-2α. Hypoxia rapidly stimulates pulmonary vascular resistance
(HPV) and increases the pressure needed to maintain normal
output from the right ventricle of the heart. We compared HPV in
WT control and mutant animals by measuring RVSPs, both im-
mediately before and during hypoxic challenge (method shown in
Fig. 3A). L1cre-HIF-2α mice have a lower resting RVSP (18.99 ±
1.00 mmHg, n = 11) than WT control animals (22.47 ±
1.19 mmHg, n = 9) (Fig. 1A); nonetheless, the magnitude of
pressure changes induced by hypoxia were still significantly lower
in mice lacking pulmonary endothelial HIF-2α (3.10 ± 0.60 mmHg,
n = 13) relative to that seen in WT animals (5.45 ± 0.76 mmHg,
n = 13, P = 0.023). RVSP recorded from L1cre-HIF-1α (4.56 ±
1.53 mmHg, n = 7) mice, however, did not significantly deviate
from WT controls (Fig. 3B) during acute hypoxic exposure. Thus,
acute pressure changes in the pulmonary circulation induced by
hypoxia are significantly lower in animals that lack HIF-2α in the
pulmonary endothelium. Baseline arterial saturations for L1cre-
HIF-2α mice did not deviate from WT controls (Fig. 3C). How-
ever, during the acute hypoxic challenge, there was a strong trend
toward greater desaturation in the L1cre-HIF-2α compared with
WT mice (Fig. 3C, P = 0.06, n = 7).
Whole-body plethysmography showed that resting ventilation
rates in normoxia are similar in the HIFα mutant animals rela-
tive to WT controls [WT control 168 ± 3.0 breaths per minute
(BrPM), L1cre-HIF-1α 174 ± 2.8 BrPM, and L1cre-HIF-2α 170 ±
2.7 BrPM] (Fig. 3D). All mice responded to acute hypoxia by
increasing ventilation rates. L1cre-HIF-1α and WT littermate
control mice increased to 258 and 250 BrPM, respectively, for
the initial 5 min before reducing their ventilation rates to 187
and 174 BrPM during the first hour of exposure to hypoxia.
However, L1cre-HIF-2α mice increased respiratory rate to
308 BrPM, then reduced their ventilation rates to 233 BrPM in the
same time period (Fig. 3D). Of note, both tidal volume and peak
inhalation/exhalation flow rates are comparable between the three
groups (Fig. S8 A–C), indicating that there is no anatomic dif-
ference in pulmonary capacity. The carotid bodies in all animals
were histologically normal (Fig. S8 D–H).
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Fig. 2. Endothelial deletion of HIF-2α maintains higher plasma nitrate lev-
els. (A) Quantitative PCR (qPCR) analysis of arginase-I/-II, NOS2, and VEGF
mRNA from whole lung samples of WT (open bar, n = 7), L1cre-HIF-1α (blue
bar, n = 7), and L1cre-HIF-2α (red bar, n = 6). (B and C) Total NO in (B) plasma
and (C) whole lung by the conversion of NO(X) to NO using an NO analyzer
(Sievers). Data shown as scatter plot with mean ± SEM from WT (n = 7),
L1cre-HIF-1α (n = 7), and L1cre-HIF-2α (n = 6) after CH challenge. (C) Whole
lung lysate analysis for NO(X) in normoxic WT (open bar, n = 7), L1cre-HIF2α
(red bar, n = 7), and L1cre-Arg1 (green bar, n = 4) and following CH (10% O2
21 d), WT (white checkered bar, n = 16), L1cre-HIF2α (red checkered bar, n =
7), and L1cre-Arg1 (green checkered bar, n = 9). (D) Exhaled NO was mea-
sured noninvasively in nonanesthetized mice. In normoxia gas phase NO was
measured by a chemiluminescence-based NO analyzer (carrier gas baseline
1.7 ppb, dotted line). Data shown as bar graph with mean ± SEM for nor-
moxic WT (n = 13), L1cre-HIF-2α (n = 8), and L1-Arg1(n = 5). Pulmonary
endothelial deletion of Arg-1 attenuates hypoxic pulmonary hypertensive
phenotype. (E) Scatter plot (mean ± SEM) shows the effect of pulmonary
endothelial Arg-1 on RVSP. WT and L1cre-Arg1 mice were housed in nor-
moxia (N) or CH (H) [WT (N) n = 5, (H) n = 7; L1cre-Arg1 (N) n = 6, (H) n = 7].
(F) Effect of pulmonary endothelial Arg-1 on RVH. Scatter plot (mean ± SEM)
shows RV/LV+S weight ratio in mice exposed to normoxia (N) or CH (H) [WT
(N) n = 6, (H) n = 6; L1cre-Arg1 (N) n = 7, (H) n = 9]. (G) Airway remodeling
was determined in WT (n = 8) and L1cre-Arg1 (n = 10). Quantification of the
intimal medial thickness. (H) Stacked bar chart showing the degree of
muscularization of peripheral pulmonary arteries in lung sections from WT
(n = 5) and L1cre-Arg1 (n = 6) mice. (I) Representative photomicrographs
immunostained for α-SMA showing near and complete ring formation in
peripheral vessel of WT mice compared with L1cre-Arg1 mice. (Scale bars,
100 μM.) (J) Total NO was determined in the plasma by the conversion of NOx
to NO using an NO analyzer (Sievers). Data shown as scatter plot with mean
± SEM from WT (n = 6) and L1cre-Arg1 (n = 8) after CH challenge. *P < 0.05,
**P < 0.001, ***P < 0.0001.
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Endothelial Progenitor Cells from Human PAH Patients Have Altered HIF-
2α–Dependent Arginase Expression.Blood outgrowth endothelial cells
(BOECs) have been extensively used as a model for studying
in vitro endothelial function in vascular disorders (29, 30) with close
functional and gene expression similarity to pulmonary artery en-
dothelial cells (31).
Previous work has shown enhanced expression and activity of
Arg-2 in PAH patients (27, 32). Fig. 4A demonstrates that these
cells have no deficiencies in HIF expression, and that Arg-2 ex-
pression is increased in the PAH patient-derived cells (Fig. 4A and
Fig. S9 A and B). Hypoxia further increases the expression of
Arg-2 in these BOECs from PAH patients.
BOECs from control volunteers produce significantly more NO
than BOECs from PAH patients following 48 h in culture (Fig.
S9C). NO production was restored to near that seen in control
BOECs following arginase inhibition with S-(2-boronoethyl)-L-
cysteine (BEC) (Fig. S9C). shRNA technology was used to spe-
cifically knock down HIF-1α, HIF-2α, and Arg-2 in these BOECs.
These data show that knockdown of HIF-2α suppresses the ex-
pression of Arg-2 (Fig. 4B) and decreases Arg-2 enzyme activity in
these cells from patients with PAH (Fig. 4C).
Discussion
In this study, we have shown that the endothelial cell is a nec-
essary element in the changes that result in PAH, and that the
HIF isoform HIF-2α is in turn required for that endothelial re-
sponse. We also observed the down-regulated expression of ar-
ginase in isolated pulmonary endothelial cells and whole lungs
from L1cre-HIF2a mice following CH and demonstrate here that
deletion of arginase-1 specifically in the pulmonary endothelium
attenuated the development of hypoxic pulmonary hypertension.
Given the role of HIF-2α in regulating arginases specifically, this
indicates that a key aspect of the function of HIF-2α in PAH is
its regulation of arginase expression.
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Fig. 4. Analysis of human BOECs as a model for studying in vitro endothelial
function in PAH. (A) Western blot analysis of HIF1α and HIF2α stability and ar-
ginase-2 expression in normoxia and 16 h posthypoxia. Data shown in bar graph
as a ratio of target gene to β-actin, mean ± SEM of control (closed bar, n = 3)
and PAH (red bar, n = 4). (B) A lentiviral shRNA strategy was used to target
HIF1α, HIF2α, and Arg-2 expression. Three shRNAs were used to knock down
each gene of interest. A scramble short hairpin and GFP-tagged lentivirus and
no treatment were included as controls. Data shown (mean ± SEM qPCR fold
change compared with no-treatment control) for Arg-2 from control (black bar,
n = 3) and PAH (red bar, n = 3) 16 h posthypoxia. (C) Cell lysates were analyzed
for arginase activity following the shRNA strategy to knock down HIF1α, HIF2α,
and Arg-2. Data are shown as mean ± SD of urea produced corrected per
milligram of protein lysate for control (black bar n = 2) and PAH (red bar n =
2). *P < 0.05, **P < 0.001 (control) and *P < 0.05, **P < 0.001(PAH).
8804 | www.pnas.org/cgi/doi/10.1073/pnas.1602978113 Cowburn et al.
The HIF pathway was implicated in PH initially through
demonstrations showing that mice hemizygous for HIF-1α or
HIF-2α have diminished levels of pulmonary hypertension (15,
33); subsequent work was able to show that hemizygosity for
HIF-1α resulted in changes in myocyte hypertrophy and polari-
zation (14). In contrast, hemizygosity of HIF-2α revealed that
endothelial changes resulting in PAH were partially blocked
when HIF-2α was diminished (15). Recent studies have also
shown that PHD2 loss, which gives rise to increased HIF protein
stability, promotes an HIF-2α–dependent increase in pulmonary
hypertension (34, 35). These studies further demonstrate the
importance of the HIF pathway in the etiology of PAH.
The causal link between pulmonary hypertension and NO ho-
meostasis has been extensively documented (26, 36), and this is
reflected clinically in the finding that intrapulmonary nitrates, bio-
chemical reaction products of NO in bronchoalveolar fluid, and
exhaled NO are all diminished in human pulmonary hypertension
(37, 38). Interestingly, primary pulmonary endothelial cells isolated
from PAH patients have substantially increased expression of arg-2
(27), which would be predicted to decrease available L-arginine and
reduce NOS-derived NO formation. We have previously shown that
both Arg1 and Arg2 are HIF-2α–dependent genes, and we show
here that their expression in pulmonary endothelium is decreased in
HIF-2α pulmonary endothelium mutants. This should result in an
increase in pulmonary endothelial NO, which itself has been shown
to alleviate PAH experimentally (39). Consistent with this hypoth-
esis, genetic deletion of arg-1 resulted in a marked attenuation in
the pathologies associated with PAH. Given a mechanistic link
between these findings and the etiology of PAH, future therapies to
manipulate the control of NO homeostasis by the HIFα pathway
should certainly be explored.
Methods
Animals. All animals were housed in a facility approved by the Association for
Assessment and Accreditation of Laboratory Animal Care International. All
protocols and surgical procedures were approved by the local and national
animal care committees. Targeted deletion of HIF-1α, HIF-2α, and arginase-1 in
pulmonary endothelial cells was created by crossing (C57Bl6/j) homozygous for
the floxed allele in HIF-1α, HIF-2α, or arginase-1 into a background of Cre
recombinase expression drive by the L1 (alk-1) promoter kindly donated by
Paul Oh, University of Florida, Gainesville, FL (17). Mice characterized as WT
were in all cases littermates of respective mutant mice, homozygous for con-
ditional alleles but without the cre recombinase transgene.
MeasurementofRVSP. For inductionofPAHdue toCH,groupsofmalemice (8–12wk)
were maintained in a normobaric hypoxic chamber (FiO2 10%) for up to 21 d. Mice
were weighed then anesthetized (isoflurane) and right-sided heart catheterization
was performed through the right jugular using a pressure-volume loop catheter
(Millar) (40–42). Blood was taken for hemodynamic assessment.
RVH. To measure the extent of RVH, the heart was removed and the right
ventricule (RV) free wall was dissected from the left ventricle plus septum
(LV+S), and weighed separately (43). The degree of RVH was determined
from the ratio RV/LV+S.
Tissue Preparation. In all animals the left lung was fixed in situ in the dis-
tended state by the infusion of 0.8% agarose into the trachea and then
placed in 10% (wt/vol) paraformaldehyde before paraffin embedding. The
right lung was frozen in liquid nitrogen for mRNA extraction.
Pulmonary Vascular Morphometry. Detailed methods are given in SI Methods.
Hematological Analysis. Anticoagulated blood was analyzed using Vet abc
hematology analyzer (Horiba) according to the manufacturer’s instructions.
Nitrite/Nitrate Analysis. Blood samples were centrifuged to separate plasma
and were passed through a column with a 10-kDa cutoff filter. All samples
were analyzed for total NO(X) content using a NOA 280i (Sievers; GE
Healthcare) according to the manufacturer’s instructions.
RNA Analysis. Detailed methods are given in SI Methods.
BOEC isolation culture. BOECs have been extensively used as a model for
studying in vitro endothelial function in vascular disorders (29, 30) and we
have previously demonstrated their close functional and gene expression
similarity to pulmonary artery endothelial cells (31). BOECs were isolated as
previously described (44). BOECs were isolated from peripheral blood was
taken from consenting healthy volunteers at the Addenbrooke’s University
of Cambridge teaching hospital National Health Service Foundation Trust,
Cambridge, United Kingdom, following a protocol approved by the Cam-
bridge Research Ethics Committee (REF:11/EE/0297). Detailed methods are
given in SI Methods.
Arginase activity assay. BOECs were prepared in lysis buffer for an arginase
activity assay as previously described (45). Detailed methods are given in
SI Methods.
Carotid Body Histology. Carotid body histology was performed as previously
reported (46). Carotid body volume and cell numbers were quantified on
microscope images (Leica DM-RB) using ImageJ software. Detailed methods
are given in SI Methods.
Whole-Body Unrestrained Plethysmography. A single-chamber plethysmograph
(Data Science) was used in conjunction with a pressure transducer. Non-
anesthetizedmicewere randomly placed into the plethysmograph and allowed
to acclimate. Once they were acclimated to the chamber, the composition of
the flow gas was switched from 21% O2 to 10% O2 using a PEGAS mixer
(Columbus Instruments). Detailed methods are given in SI Methods.
Exhaled NO analysis. Exhaled NO was measured noninvasively in non-
anesthetizedmice using a closed chamber system as previously described (47).
Briefly, gas phase NO was measured by a chemiluminescence-based NO
analyzer sensitive to 0.1ppb NO (NOA 280i; Sievers). Detailed methods are
given in SI Methods.
Primary lung endothelial cell isolation. Primary endothelial cells were isolated
and cultured from lungs of L1cre-HIF2α and WT mice, as previously described
(25). Detailed methods are given in SI Methods.
Knockdown experiments. Human BOECs derived from both control and PAH
donors were transduced using lentiviral particles containing three different
shRNAs targeting human HIF-1α, HIF-2α, and Arg-2 mRNA, respectively.
Detailed methods are given in SI Methods.
Statistical Analysis. All data represents the mean (±SEM) of n separate experi-
ments unless otherwise stated. Difference between groups was assessed using t
test unless otherwise stated. A P value of <0.05 was considered significant.
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